Plaintiff
Defendant
- Parties: The plaintiffs were Bayer Inc. and Regeneron Pharmaceuticals Inc. The defendants were Celltrion, Inc., Celltrion Healthcare Canada Ltd, Celltrion Healthcare Co Ltd, and Celltrion Pharm Inc.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations. This case is ongoing.
- Date: The hearing was set on May 27, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-96-24Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
16 January 2024Download documents